Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,513,109
-$515,011 QoQ
Shares Held
127,889
-14.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. GMAB ranks #40 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,513,109 | 127,889 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,028,120 | 150,135 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,542,936 | 147,498 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,560,539 | 116,092 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,423,168 | 117,288 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $2,360,661 | 120,565 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $6,761,919 | 324,002 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,450,676 | 797,813 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,921,904 | 792,754 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $23,460,563 | 784,372 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $20,409,087 | 640,989 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,479,015 | 835,810 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,254,992 | 717,048 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,829,164 | 604,586 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,373,793 | 598,721 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $21,994,908 | 684,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,123,821 | 742,500 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,243,527 | 670,081 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,519,560 | 645,085 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,239,517 | 623,330 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,875,133 | 584,745 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,410,566 | 530,325 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $23,892,910 | 587,627 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $19,511,076 | 532,944 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $15,770,606 | 465,347 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $10,608,389 | 500,632 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||